Compare YELP & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YELP | SDGR |
|---|---|---|
| Founded | 2004 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2011 | 2020 |
| Metric | YELP | SDGR |
|---|---|---|
| Price | $26.16 | $16.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $29.17 | $21.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 19.15 | ★ 45.14 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $1,464,955,000.00 | $255,869,000.00 |
| Revenue This Year | $2.19 | $0.76 |
| Revenue Next Year | $2.34 | $4.60 |
| P/E Ratio | $87.50 | ★ N/A |
| Revenue Growth | 3.75 | ★ 23.29 |
| 52 Week Low | $19.60 | $10.95 |
| 52 Week High | $35.26 | $23.75 |
| Indicator | YELP | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 63.35 | 60.33 |
| Support Level | $23.50 | $11.27 |
| Resistance Level | $29.99 | $16.47 |
| Average True Range (ATR) | 1.02 | 1.03 |
| MACD | 0.38 | 0.08 |
| Stochastic Oscillator | 99.23 | 60.97 |
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.
Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.